On March 28, 2024, Shenzhen Beike Biotechnology Co., Ltd. (hereinafter "Beike Biotech") and Beijing Sino Biological Inc. (hereinafter "Sino Biological", stock code 301047) officially signed a strategic cooperation agreement in Shenzhen. The two parties will cooperate deeply on research and scientific research services in stem cells, immune cells, and organoid culture reagents, jointly working on breakthroughs in the R&D of high-quality bio-reagents and technology research in stem cells, immune cells, organoids, and other areas. Going forward, the two parties will join hands and empower one another, fully leveraging their respective strengths in resources, capital, technology, and management to jointly advance the development of the cell industry. Dr. Hu Junyuan, Chairman of Beike Biotech, and Dr. Zhang Jie, General Manager of Sino Biological, attended the signing ceremony.
Sino Biological is a domestic expert in the R&D and production of proteins and antibodies, focusing on providing comprehensive, high-quality recombinant proteins, antibodies, and other bio-reagents and professional, one-stop technical services for life science research and innovative drug R&D. Beike Biotech is a national high-tech enterprise specializing in the clinical translation and technical services of biotherapy technologies in strategic emerging industries, with a professional R&D team led by multiple expert-level scholars of outstanding achievement in the cell field.
This strategic cooperation will combine Beike Biotech's technical strength in basic cell research and clinical translation of biotherapy technologies with Sino Biological's R&D capabilities and large-scale production capacity in bio-reagents. Drawing on each other's core scientific advantages, the two parties will work together to overcome the "bottleneck" challenges in the R&D of high-quality bio-reagents in stem cells, immune cells, and organoids, and jointly develop more high-quality products and services to meet market demands in basic research and clinical applications, jointly advancing the global life and health cause.
